Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients

Michael H. AldermanS Madhavan


Short-acting calcium antagonists may increase coronary artery morbidity, mortality, and non-cardiovascular complications in hypertensive patients. We assessed whether this association was also true for long-acting calcium antagonists. We did a case-control study, which was nested within a systematic hypertension control programme for a prospective cohort of 4350 people (first seen 1981-94). Cases (n = 189) were hypertensive patients who had had a first cardiovascular event, including all cardiovascular deaths and hospitalisations, between 1989 and 1995. Controls (n = 189) were individually matched to cases for sex, ethnic origin, age, type of previous antihypertensive treatment, year of entry into the study, and length of follow-up. We collected data on any prescribed drug regimen that was being taken on the event data for cases and on the same date for matched controls. Calcium antagonists were classified by duration of action. Compared with those on beta-blocker monotherapy, patients on long-acting calcium antagonists (n = 136) had no increased risk of a cardiovascular event (adjusted odds ratio 0.76 [95% CI 0.41-1.43]), whereas patients on short-acting calcium antagonists (n = 27) were at significantly greater risk (adjusted...Continue Reading


Dec 1, 1976·Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association·Michael H. Alderman, T Davis
Jul 10, 1975·The New England Journal of Medicine·Michael H. Alderman, E E Schoenbaum
Nov 1, 1983·Hypertension·Michael H. AldermanT Davis
Nov 1, 1995·Journal of the American Geriatrics Society·M PahorR Havlik
Aug 23, 1995·JAMA : the Journal of the American Medical Association·B M PsatyP W Wahl
Sep 1, 1996·Journal of the American Geriatrics Society·M PahorC H Hennekens
Jan 1, 1996·Journal of Hypertension·G Mancia, P A van Zwieten


Sep 12, 2000·Current Hypertension Reports·W H Birkenhäger, J A Staessen
Jun 9, 2001·Disease-a-month : DM·Robert A O'Rourke
Sep 28, 2002·Journal of Chromatography. a·Markus WallesJürgen Borlak
Dec 1, 2001·Heart Disease·D C O'LoughlinD Singh
Jan 13, 1998·Journal of the American College of Cardiology·J W LeitchR Heller
Oct 20, 1999·Journal of Clinical Epidemiology·W RathmannG Giani
Mar 5, 1998·The New England Journal of Medicine·J A Cutler
Oct 17, 2008·Cardiology in Review·Zainab SamadL Kristin Newby
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·Susan M Abdel-Rahman, Ralph E Kauffman
Apr 5, 2003·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kizuku KuramotoT Ogihara
Jun 2, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Minori NakamotoShuichi Takishita
Aug 5, 2000·Clinical Pharmacokinetics·E L Michalets, C R Williams
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·C Venkata S Ram
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Michael A Weber
Sep 1, 2005·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Paolo Verdecchia, Fabio Angeli
Nov 23, 2000·Journal of General Internal Medicine·E L KnightJ Avorn
Mar 3, 1998·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·P A Meredith
Aug 15, 2001·Pharmacoepidemiology and Drug Safety·K A Jassim al KhajaV S Mathur
Jul 14, 2010·Current Problems in Cardiology·Robert A O'Rourke
Sep 1, 2009·Transplantation Proceedings·R M López-PintorA de Andrés
Jul 21, 2009·Progress in Cardiovascular Diseases·Paolo Palatini
Jan 17, 2002·Mayo Clinic Proceedings·Brian M Curtis, James H O'Keefe
Mar 31, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A CovicM Covic
Mar 9, 2006·The Journal of Clinical Hypertension·Thomas G Pickering
Mar 26, 2016·Pharmacology & Therapeutics·Andreas A GiannopoulosYiannis S Chatzizisis
Aug 7, 1999·The American Journal of Cardiology·P A Meredith
Jan 7, 2004·The American Journal of Medicine·Mark J EisenbergAlain N Bestawros
Dec 17, 1997·The American Journal of Cardiology·E Grossman, F H Messerli
May 20, 1998·The American Journal of Cardiology·R A KlonerM Levenstein
May 8, 2007·The American Journal of Geriatric Cardiology·Esther Paran, Ofra Anson
Sep 4, 2015·Lancet·Steen E Husted, E Magnus Ohman
May 20, 2015·JAAPA : Official Journal of the American Academy of Physician Assistants·Deepali Dixit, Katarzyna Kimborowicz
May 14, 1999·Journal of the American Geriatrics Society·M W GillmanS B Soumerai
Sep 11, 2010·Journal of the American College of Cardiology·William E Boden
Mar 10, 2015·Revista de calidad asistencial : organo de la Sociedad Española de Calidad Asistencial·J E Machado-AlbaM E Machado-Duque
Jul 26, 2011·International Journal of Hypertension·Oladipupo OlafiranyeGbenga Ogedegbe
Sep 25, 2014·Annual Review of Pharmacology and Toxicology·R D FeldmanS W Tobe
Apr 6, 2007·Journal of Pharmacological Sciences·Daisuke NishiyaMinoru Yoshiyama
Aug 3, 2016·American Journal of Hypertension·David G BaileyJohn Malcolm Arnold
Nov 26, 2008·Pharmacoepidemiology and Drug Safety·M M Joffe
Nov 26, 2008·Pharmacoepidemiology and Drug Safety·C J MaxwellE M Ebly
Nov 26, 2008·Pharmacoepidemiology and Drug Safety·D M HuseS C Hartz
Apr 17, 2003·European Journal of Clinical Pharmacology·Raffaele Antonelli IncalziPierugo Carbonin
Apr 22, 2008·Clinical and Experimental Hypertension : CHE·Tomoyuki KabutoyaJMS-1 Study Group
May 26, 1999·Current Problems in Cardiology·M FreherM Gheorgiade
Feb 23, 2005·Expert Review of Cardiovascular Therapy·Roberto PontremoliAngelica Parodi
Jul 4, 2001·The British Journal of Psychiatry : the Journal of Mental Science·R Perkins
Apr 18, 2003·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Howard TrachtmanMichael Klibaner
Mar 3, 1998·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·F R Bühler
Aug 9, 2003·Expert Opinion on Drug Safety·Joseph T Flynn
Oct 26, 2005·Circulation Journal : Official Journal of the Japanese Circulation Society·Takaaki TaniwaKinji Ishikawa

Related Concepts

Antihypertensive Agents
Calcium Channel Blockers
Cardiovascular Diseases
Hypertensive Disease
Regression Analysis
Incidence Studies
Logistic Regression
Odds Ratio
Nested Case-Control Studies

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.